Logo
x

Search category

Subscribe Now

AEON Biopharma

AEON Biopharma Reports P-II Trial Results of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine

AEON Biopharma Reports P-II Trial Results of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine

  • October 20, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.